117 related articles for article (PubMed ID: 36456139)
21. SIRT3 is correlated with the malignancy of non-small cell lung cancer.
Xiong Y; Wang M; Zhao J; Wang L; Li X; Zhang Z; Jia L; Han Y
Int J Oncol; 2017 Mar; 50(3):903-910. PubMed ID: 28197634
[TBL] [Abstract][Full Text] [Related]
22. Therapy-related Myeloid Leukemia With the Translocation t(8;19)(p11;q13) Leading to a
Panagopoulos I; Andersen K; Ramslien LF; Ikonomou IM; Micci F; Heim S
Anticancer Res; 2021 Apr; 41(4):1753-1760. PubMed ID: 33813379
[TBL] [Abstract][Full Text] [Related]
23. Differential
Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
[TBL] [Abstract][Full Text] [Related]
24. Gastric Adenocarcinoma Predictive Long Intergenic Non-Coding RNA Promotes Tumor Occurrence and Progression in Non-Small Cell Lung Cancer via Regulation of the miR-661/eEF2K Signaling Pathway.
Gu H; Chen J; Song Y; Shao H
Cell Physiol Biochem; 2018; 51(5):2136-2147. PubMed ID: 30522114
[TBL] [Abstract][Full Text] [Related]
25. PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer.
Xiong S; Zheng Y; Jiang P; Liu R; Liu X; Qian J; Gu J; Chang L; Ge D; Chu Y
Br J Cancer; 2014 Jan; 110(2):353-62. PubMed ID: 24281003
[TBL] [Abstract][Full Text] [Related]
26. Lysine acetyltransferase 6A maintains CD4
Fu JY; Huang SJ; Wang BL; Yin JH; Chen CY; Xu JB; Chen YL; Xu S; Dong T; Zhou HN; Ma XY; Pu YP; Li H; Yang XJ; Xie LS; Wang ZJ; Luo Q; Shao YX; Ye L; Zong ZR; Wei XD; Xiao WW; Niu ST; Liu YM; Xu HP; Yu CQ; Duan SZ; Zheng LY
Cell Metab; 2024 Mar; 36(3):557-574.e10. PubMed ID: 38237601
[TBL] [Abstract][Full Text] [Related]
27. Expression of Zyxin in Non-Small Cell Lung Cancer-A Preliminary Study.
Partynska A; Gomulkiewicz A; Piotrowska A; Grzegrzolka J; Rzechonek A; Ratajczak-Wielgomas K; Podhorska-Okolow M; Dziegiel P
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740950
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer.
Ratajczak-Wielgomas K; Kmiecik A; Grzegrzołka J; Piotrowska A; Gomulkiewicz A; Partynska A; Pawelczyk K; Nowinska K; Podhorska-Okolow M; Dziegiel P
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987711
[TBL] [Abstract][Full Text] [Related]
29. The oncogenic role of CB2 in the progression of non-small-cell lung cancer.
Xu S; Ma H; Bo Y; Shao M
Biomed Pharmacother; 2019 Sep; 117():109080. PubMed ID: 31176172
[TBL] [Abstract][Full Text] [Related]
30. Expression of tesmin (MTL5) in non‑small cell lung cancer: A preliminary study.
Grzegrzolka J; Gomulkiewicz A; Olbromski M; Glatzel-Plucinska N; Piotrowska A; Ratajczak-Wielgomas K; Rzechonek A; Podhorska-Okolow M; Krawczuk Z; Dziegiel P
Oncol Rep; 2019 Jul; 42(1):253-262. PubMed ID: 31059101
[TBL] [Abstract][Full Text] [Related]
31. Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers.
Shimizu H; Yamagishi S; Chiba H; Ghazizadeh M
Adv Clin Exp Med; 2016; 25(1):117-28. PubMed ID: 26935506
[TBL] [Abstract][Full Text] [Related]
32. KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP.
Jin Y; Yang R; Ding J; Zhu F; Zhu C; Xu Q; Cai J
Biochem Biophys Res Commun; 2021 Dec; 585():185-190. PubMed ID: 34808502
[TBL] [Abstract][Full Text] [Related]
33. EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer.
Cao W; Ribeiro Rde O; Liu D; Saintigny P; Xia R; Xue Y; Lin R; Mao L; Ren H
PLoS One; 2012; 7(12):e52984. PubMed ID: 23300840
[TBL] [Abstract][Full Text] [Related]
34. [FOXC1 Knockdown Reverses Gefitinib Resistance in Non-small Cell Lung Cancer].
Peng C; Li P; Yang M; Chen D; Huang Y
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):538-547. PubMed ID: 34334155
[TBL] [Abstract][Full Text] [Related]
35. Ornithine decarboxylase mRNA expression in curatively resected non-small-cell lung cancer.
Grimminger PP; Schneider PM; Metzger R; Vallböhmer D; Danenberg KD; Danenberg PV; Hölscher AH; Brabender J
Clin Lung Cancer; 2010 Mar; 11(2):114-9. PubMed ID: 20199977
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
[TBL] [Abstract][Full Text] [Related]
37. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
Zhang X; Zhang X; Yu B; Hu R; Hao L
Biochimie; 2017 Jun; 137():12-19. PubMed ID: 28223039
[TBL] [Abstract][Full Text] [Related]
38. Over-expression of small ubiquitin-like modifier proteases 1 predicts chemo-sensitivity and poor survival in non-small cell lung cancer.
Mu J; Zuo Y; Yang W; Chen Z; Liu Z; Tu J; Li Y; Yuan Z; Cheng J; He J
Chin Med J (Engl); 2014; 127(23):4060-5. PubMed ID: 25430449
[TBL] [Abstract][Full Text] [Related]
39. [Role of heterogeneous nuclear ribonucleoprotein A2/B1 protein in the pathogenesis of non-small cell lung cancer].
Shi Y; Chen Y; Hou YY; Ji CH; Hu Q; Zhou Y; Su JA; Tan YS
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):110-4. PubMed ID: 21575478
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of the non-coding SOX2OT variants 4 and 7 in lung tumors suggests an oncogenic role in lung cancer.
Saghaeian Jazi M; Samaei NM; Ghanei M; Shadmehr MB; Mowla SJ
Tumour Biol; 2016 Aug; 37(8):10329-38. PubMed ID: 26846097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
